Table 2.
. | CLINICAL SEVERITY OF COVID-19 |
SIGNIFICANCE |
|||
---|---|---|---|---|---|
All | Mild | Moderate | Severe | p-value | |
Age (Mean ± S.D) | 42.63 ± 16.04 | 39.41 ± 15.73 | 48.58 ± 9.86 | 57.70 ± 10.58 | 0.002 |
Sex (n, %) Male Female |
87 (58.8%) 61 (41.22%) |
63 (72.41%) 53 (86.88%) |
9 (10.3%) 3 (4.9%) |
15 (17.2%) 5 (8.2%) |
0.109 |
TLC (Mean ± S.D) | 8631.82 ± 4284.27 | 7225.78 ± 2657.82 | 11778.50 ± 3666.66 | 14899.50 ± 5639.44 | <0.05 |
NEUTROPHILS (Mean ± S.D) | 64.92 ± 17.14 | 59.35 ± 14.13 | 80.16 ± 13.24 | 88.04 ± 8.05 | <0.05 |
LYMPHOCYTES (Mean ± S.D) | 24.96 ± 14.22 | 29.19 ± 12.35 | 13.0 ± 10.90 | 7.58 ± 7.34 | <0.05 |
MONOCYTE (Mean ± S.D) | 6.86 ± 3.77 | 7.62 ± 3.61 | 5.11 ± 3.62 | 3.52 ± 2.52 | <0.05 |
EOSINOPHIL (Mean ± S.D) | 2.32 ± 2.53 | 2.72 ± 2.63 | 1.23 ± 2.03 | 0.68 ± 0.87 | <0.05 |
BASOPHIL (Mean ± S.D) | 0.25 ± 0.53 | 0.28 ± 0.59 | 0.17 ± 0.22 | 0.14 ± 0.21 | 0.166 |
NLR (Mean ± S.D) | 7.79 ± 17.72 | 3.82 ± 10.28 | 15.18 ± 14.87 | 26.39 ± 34.15 | <0.05 |
NMR (Mean ± S.D) | 25.12 ± 88.54 | 11.57 ± 15.38 | 31.66 ± 39.69 | 99.76 ± 226.47 | <0.05 |
LMR (Mean ± S.D) | 5.00 ± 6.64 | 5.16 ± 6.36 | 3.16 ± 45.47 | 5.14 ± 8.82 | 0.565 |
Categorical data was expressed in frequency and percentage (%). Quantitative data was expressed in mean ± S.D. p values were calculated from Chi-square tests and One way ANOVA. Bold data indicated p < 0.05. TLC- Total leukocyte count, NLR- Neutrophil-Lymphocyte ratio, NMR- Neutrophil-Monocyte ratio, LMR- Lymphocyte-Monocyte ratio.